(19)
(11) EP 4 010 004 A2

(12)

(88) Date of publication A3:
11.03.2021

(43) Date of publication:
15.06.2022 Bulletin 2022/24

(21) Application number: 20851042.0

(22) Date of filing: 06.08.2020
(51) International Patent Classification (IPC): 
A61K 38/00(2006.01)
C07K 19/00(2006.01)
C12N 15/85(2006.01)
C07K 14/195(2006.01)
C12N 15/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 15/85; C12N 2830/005; C07K 14/7051; C07K 2319/03; C07K 2319/71; C07K 2319/81; C07K 14/70521; C07K 14/70503; C07K 14/70596; C07K 2319/80; C12N 9/22
(86) International application number:
PCT/US2020/045174
(87) International publication number:
WO 2021/026336 (11.02.2021 Gazette 2021/06)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 07.08.2019 US 201962884028 P
10.09.2019 US 201962898434 P
18.11.2019 US 201962937011 P

(71) Applicant: I Altius Institute for Biomedical Sciences
Seattle WA 98121 (US)

(72) Inventors:
  • URNOV, Fyodor
    Seattle, Washington 98121 (US)
  • STAMATOYANNOPOULOS, John A.
    Seattle, Washington 98121 (US)
  • PEARL, Joycelynn
    Seattle, Washington 98121 (US)
  • WILKEN, Matthew
    Seattle, Washington 98121 (US)
  • CIARLO, Christie
    Seattle, Washington 98121 (US)
  • GREEN, Shon
    Seattle, Washington 98121 (US)

(74) Representative: Boult Wade Tennant LLP 
Salisbury Square House 8 Salisbury Square
London EC4Y 8AP
London EC4Y 8AP (GB)

   


(54) COMPOSITIONS AND METHODS FOR MODULATION OF GENE EXPRESSION